Abdullah Jahangir

Abdullah Jahangir

Auto-generated profile, based on publicly available information

Abdullah Jahangir

Staten Island University Hospital, Staten Island, NY, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
SSSyeda Sahra
Syeda Sahra
AJAbdullah Jahangir
Abdullah Jahangir
RHRachelle Hamadi
Rachelle Hamadi
AJAhmad Jahangir
Ahmad Jahangir
AGAllison Glaser
Allison Glaser
Sahra S, et al. Infect Chemother. 2021 Jun;53(2):271-283. https://doi.org/10.3947/ic.2021.0051

Verified
Journal Article
Open access
AJAbdullah Jahangir
Abdullah Jahangir
ZZZeeshan Zia
Zeeshan Zia
MNMuhammad Rafay Khan Niazi
Muhammad Rafay Khan Niazi
SSSyeda Sahra
Syeda Sahra
AJAhmad Jahangir
Ahmad Jahangir
MCMichel Chalhoub
Michel Chalhoub
Introduction: Magnesium sulfate has been extensively used to treat asthma exacerbations, but its efficacy remains questionable in the chronic obstructive pulmonary disease (COPD) population. The aim of the study was to compare the efficacy of intravenous (IV) magnesium sulfate in COPD. A systemic review search was conducted on PubMed, Embase, and the Central Cochrane Registry. Randomized clinical trials were included with magnesium sulfate as an intervention arm in the COPD population. Materials and Methods: For continuous variables, standardized mean difference (SMD) and difference in means (MD) were calculated. For discrete variables, the Mantel-Haenszel (MH) odds ratio was used. For effect sizes, a confidence interval of 95% was used. A p-value of less than 0.05 was used for statistical significance. Analysis was done using both random and fixed effect models. Heterogeneity was evaluated using the I² statistic. Results: Seven studies were included in the final analysis. In patients with acute exacerbations of COPD treated with IV magnesium, a significant increase in forced expiratory volume in one second (FEV₁) was observed (MD = 2.537 [0.717 to 4.357], p = 0.006), as well as in peak expiratory flow rate (PEFR) (SMD = 1.073 [0.748 to 1.397], p < 0.001) using the fixed model. Similarly, residual volume decreased significantly in the IV magnesium group (MD = –0.470 [–0.884 to –0.056], p = 0.026). The hospitalization rate was also lower in the magnesium group, (MH odds ratio 0.453 [0.233 to 0.882], p = 0.020). No statistically significant difference was noted in FEV₁ in the stable COPD population. Conclusion: IV magnesium was associated with a favorable deviation of FEV1 and PEFR, decreased residual volume, and decreased odds of admission in the COPD exacerbation population. Therefore, magnesium sulfate can be used as an adjunctive therapy in the treatment of acute exacerbations of COPD.

9 April 2021 in Case Reports in Critical Care
Verified
Journal Article
Open access
PDF file
JTJoshua Twito
Joshua Twito
SSSyeda Sahra
Syeda Sahra
AJAbdullah Jahangir
Abdullah Jahangir
NMNeville Mobarakai
Neville Mobarakai
Background. Central venous catheters (CVCs) have been frequently associated with septic thrombophlebitis, bacteremia, and septic emboli. Right-sided infective endocarditis is seen concurrently in patients with septic pulmonary emboli. A case of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and septic pulmonary emboli secondary to infected peripheral venous catheter (PVC) is reported. Transesophageal echocardiogram (TEE) showed no evidence of infective endocarditis. Case Presentation. A 44-year-old female presented to E.R. with left upper extremity pain and swelling at the previously inserted peripheral 18-gauge intravenous catheter site. She also had chest pain, which worsened with inspiration. The patient was found to be in septic shock. Her clinical condition deteriorated acutely. Right upper extremity deep venous thrombosis (DVT) and pulmonary emboli were seen on imaging. Blood cultures grew MRSA. Transthoracic and transesophageal echocardiograms showed no vegetations. The patient responded well to appropriate antibiotics and anticoagulation. Conclusion. Peripherally inserted catheters are an important portal for pathogen entry and need periodic site assessment and frequent evaluation of their need for insertion. Septic pulmonary emboli can also be seen without any evidence of right-sided infective endocarditis.

1 January 2021 in Infection & Chemotherapy
Verified
Journal Article
Open access
AJAbdullah Jahangir
Abdullah Jahangir
SSSyeda Sahra
Syeda Sahra
Jahangir A, et al. Infect Chemother. 2021 Sep;53:e50. https://doi.org/10.3947/ic.2021.0089